Can Aspergillosis Be Cured? Understanding Treatment, Control, and Long-Term Therapy

Last reviewed: April 2026

Key points

Aspergillosis is caused by fungi from the Aspergillus group.
Most people breathe in Aspergillus spores regularly without becoming ill.
In some people, damaged airways, lung cavities, mucus plugs, or immune responses allow the fungus or fungal material to persist.
Antifungal treatment may aim to cure, but in many cases the goal is long-term control.
Steroids can reduce harmful inflammation in allergic disease, but they can also reduce the body’s ability to clear fungus.

Overview
Why breathing in spores does not usually cause disease
Why aspergillosis can be hard to clear
Infection and ABPA: different reasons for persistence
Do steroids influence this?
Control vs cure
Common antifungal treatments
Why you may not hear many success stories
When to seek medical advice
Common questions

Overview

It is very common for people diagnosed with aspergillosis to feel worried when they read that others have been taking antifungal medication for months or even years.

This can lead to an understandable question:

“Does treatment actually work, or will I have this forever?”

The answer is more nuanced than a simple yes or no. Different forms of aspergillosis behave differently, and treatment goals vary depending on the condition.

Two of the most common conditions are:

Allergic Bronchopulmonary Aspergillosis (ABPA) – an allergic immune reaction to Aspergillus in the airways
Chronic Pulmonary Aspergillosis (CPA) – a long-term fungal infection, usually in areas of damaged lung tissue

Understanding this difference is key to understanding why treatment may continue for a long time.

If you would like a more detailed explanation of how these conditions are diagnosed and managed, see our guides to chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA).

Why breathing in spores does not usually cause disease

Aspergillus spores are present in the environment, including air, soil, compost, dust, and decaying vegetation. Most people breathe in small numbers of these spores regularly without becoming ill.

In healthy lungs, spores are usually cleared by the immune system and by the normal cleaning mechanisms of the airways.

This means:

Exposure to Aspergillus is common
Most exposure does not lead to disease
Aspergillosis usually develops only when there are additional risk factors, such as lung damage, mucus trapping, or altered immune responses

So it is not accurate to think of most patients as being “constantly reinfected”. A better way to think about it is that some lungs provide conditions where Aspergillus, or fungal material, can persist and continue to cause problems.

Why aspergillosis can be hard to clear

Aspergillosis can be difficult to clear for several reasons. These include the structure of the lungs, the biology of the fungus, limitations of drug penetration, and the way the immune system responds.

1. Damaged lung tissue can provide protected spaces

In CPA, Aspergillus often grows in areas of abnormal lung, such as cavities, scarred tissue, or areas affected by bronchiectasis.

These areas can act as protected spaces where the fungus is harder for the immune system and antifungal medicines to reach.

2. Thick mucus can trap fungus and fungal material

In airway diseases such as asthma, bronchiectasis, and ABPA, thick mucus can trap spores, hyphae, and fungal fragments.

This trapped material can continue to stimulate inflammation even when the fungus is not invading lung tissue.

3. Antifungal medicines may suppress rather than sterilise

Antifungal medications can reduce fungal activity and help prevent progression, but they may not always remove every trace of fungus from damaged lung spaces or mucus-filled airways.

For this reason, success is often measured by:

Improved symptoms
Stabilised weight and energy
Fewer flare-ups
Stable or improved scans
Prevention of further lung damage

Infection and ABPA: different reasons for persistence

Chronic pulmonary aspergillosis: persistence of infection

In chronic pulmonary aspergillosis, the problem is fungal growth in damaged lung tissue.

Lung cavities provide spaces where fungus can grow
Drug penetration may be limited
The immune system may not fully clear infection

Allergic bronchopulmonary aspergillosis: persistence of reaction

In ABPA, the main issue is an exaggerated immune response.

Mucus traps fungal material
Small amounts can trigger strong reactions
Inflammation leads to more mucus

Do steroids influence this?

Yes. Steroids can be helpful but must be used carefully.

In ABPA, they reduce inflammation but may also reduce fungal clearance.

In chronic infection, steroids can increase the risk of persistence or progression.

Monitoring and drug interactions are important during treatment.

Control vs cure: what is the goal?

For many people, the realistic goal is:

Stability rather than eradication
Reduced symptoms
Prevention of progression

Diagram showing why aspergillosis is often controlled rather than cured, including differences between ABPA and chronic pulmonary aspergillosis (CPA) — Aspergillosis is often managed as a long-term condition. This diagram shows why complete cure can be difficult and how treatment focuses on control.

Common antifungal treatments

Itraconazole
Voriconazole
Posaconazole

These treatments are selected based on individual factors and require monitoring.

Why don’t I hear many success stories?

People who improve often post less, while those still struggling are more visible in forums.

When to seek medical advice

Uncertainty about treatment
Side effects
Weight loss
Worsening symptoms

Common questions